Upgrade to SI Premium - Free Trial

AbbVie (ABBV) shares rise on earnings beat - prepared for loss of Humira exclusivity

February 9, 2023 10:00 AM
AbbVie (NYSE: ABBV) shares are up more than 3% in early Thursday trading after the company topped earnings estimates for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Earnings Guidance Hot List

Next Articles